137 related articles for article (PubMed ID: 28373473)
21. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of telomere function in gastric cancers with and without microsatellite instability.
Pascua I; Fernández-Marcelo T; Sánchez-Pernaute A; de Juan C; Head J; Torres-García AJ; Iniesta P
Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):162-9. PubMed ID: 25486025
[TBL] [Abstract][Full Text] [Related]
23. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
24. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
[TBL] [Abstract][Full Text] [Related]
25. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
26. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study.
Sun Y; Gu J; Ajani JA; Chang DW; Wu X; Stroehlein JR
Cancer; 2014 Oct; 120(19):3040-8. PubMed ID: 24962126
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic characteristics and prognosis of gastric cancer invading the subserosa.
Jiang CG; Wang ZN; Sun Z; Liu FN; Yu M; Xu HM
J Surg Oncol; 2010 Dec; 102(7):737-41. PubMed ID: 21104924
[TBL] [Abstract][Full Text] [Related]
28. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features and prognostic factors of proximal gastric carcinoma in a population with high Helicobacter pylori prevalence: a single-center, large-volume study in Korea.
Park JC; Lee YC; Kim JH; Kim YJ; Lee SK; Shin SK; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2010 Mar; 17(3):829-37. PubMed ID: 19882188
[TBL] [Abstract][Full Text] [Related]
30. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.
Tanaka K; Nishioka J; Kato K; Nakamura A; Mouri T; Miki C; Kusunoki M; Nobori T
Jpn J Cancer Res; 2001 Sep; 92(9):952-8. PubMed ID: 11572763
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer.
Yokobori T; Mimori K; Ishii H; Iwatsuki M; Tanaka F; Kamohara Y; Ieta K; Kita Y; Doki Y; Kuwano H; Mori M
Ann Surg Oncol; 2010 Oct; 17(10):2601-7. PubMed ID: 20422456
[TBL] [Abstract][Full Text] [Related]
32. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
33. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
34. Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.
Russo A; Modica F; Guarrera S; Fiorito G; Pardini B; Viberti C; Allione A; Critelli R; Bosio A; Casetta G; Cucchiarale G; Destefanis P; Gontero P; Rolle L; Zitella A; Fontana D; Frea B; Vineis P; Sacerdote C; Matullo G
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2439-46. PubMed ID: 25234236
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
36. Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival.
Svenson U; Roos G; Wikström P
Tumour Biol; 2017 Feb; 39(2):1010428317692236. PubMed ID: 28222672
[TBL] [Abstract][Full Text] [Related]
37. Prognostic relevance of Tensin4 expression in human gastric cancer.
Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
Ann Surg Oncol; 2008 Sep; 15(9):2606-13. PubMed ID: 18612693
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer.
Liu N; Zhang LH; Du H; Hu Y; Zhang GG; Wang XH; Li JY; Ji JF
Ann Surg Oncol; 2010 Oct; 17(10):2628-39. PubMed ID: 20383661
[TBL] [Abstract][Full Text] [Related]
39. Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients.
Chen Y; Wu Y; Huang X; Qu P; Li G; Jin T; Xing J; He S
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1739-47. PubMed ID: 25702101
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]